MDB Capital (MDBH)
Builds early-stage technology ventures through brokerage, IP services, and company formation.
MDB Capital Holdings, LLC (MDBH) Q2 2026 Earnings Call Transcript
MDB Capital Holdings, LLC (MDBH) Q2 2026 Earnings Call Transcript
What Is OpenAI Actually Patenting? PatentVest Pulse Analyzes OpenAI's Patent Portfolio
DALLAS, Texas, July 23, 2026 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence, strategy, and law firm, today released its latest PatentVest Pulse, an in-depth analysis of OpenAI's published patent portfolio and intellectual property strategy. Titled "What Is OpenAI Actually Patenting?
What Is OpenAI Actually Patenting? PatentVest Pulse Analyzes OpenAI's Patent Portfolio
New PatentVest Pulse report reveals how OpenAI's published patent portfolio maps its AI product strategy across conversational AI, AI agents, generative media, developer platforms, personalization, and infrastructure New PatentVest Pulse report reveals how OpenAI's published patent portfolio maps its AI product strategy across conversational AI, AI agents, generative media, developer platforms, personalization, and infrastructure
PatentVest Publishes New IP Legal Insights Article Examining Why Patent Prosecution Is Ready for AI
Dallas, TX, July 02, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced the publication of a new article in its IP Legal Insights section, continuing the firm's commitment to providing practical legal guidance on the technologies and legal developments reshaping intellectual property.
PatentVest Releases New PatentVest Pulse Report Exploring the Strategic Shift Beyond GLP-1
The new PatentVest Pulse report examines how FGF21 is emerging as the next strategic cardiometabolic layer beyond GLP-1, reshaping obesity therapeutics, pharmaceutical partnerships, and intellectual property strategy The report analyzes more than $10. 7 billion in recent acquisitions and licensing activity, highlighting how leading pharmaceutical companies are positioning themselves for the next phase of obesity innovation Dallas, TX, June 30, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the release of its latest PatentVest Pulse report, "The Crossover: How FGF21 Became the Cardiometabolic Layer Beneath GLP-1.
PatentVest to Present at Planet MicroCap Las Vegas on June 17
PatentVest Will Discuss Intellectual Property Strategy, Innovation Intelligence, and the Future of AI-Native IP Services PatentVest Will Discuss Intellectual Property Strategy, Innovation Intelligence, and the Future of AI-Native IP Services
New PatentVest Pulse Report Maps the Emerging Muscle-Preservation Category Expanding the GLP-1 Opportunity
• Analysis of 20 muscle-preservation programs highlights a rapidly emerging category designed to enhance long-term obesity treatment outcomes • PatentVest's report reveals how combination therapy IP, body-composition optimization, and strategic acquisitions may shape the next phase of obesity therapeutics Dallas, Texas, June 04, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, "The Muscle Problem: How Myostatin Could Expand the GLP-1 Opportunity" This comprehensive study provides a strategic analysis of the emerging muscle-preservation category developing alongside obesity therapies.
PatentVest Launches New Case Studies Section Featuring Strategic AI IP Engagement with Docana
� New case study highlights how PatentVest helped Docana navigate a complex AI patent landscape through freedom-to-operate analysis, competitive intelligence, and strategic IP positioning. · The launch introduces a new Case Studies section on the PatentVest website focused on real-world examples of strategic IP leadership and innovation management.
MDB Capital Holdings, LLC (MDBH) Q4 2025 Earnings Call Transcript
MDB Capital Holdings, LLC (MDBH) Q4 2025 Earnings Call Transcript
PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork
Dallas, TX, March 30, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced a new addition to its IP Legal Insights section on the company website, a platform dedicated to sharing expert legal perspectives on intellectual property strategy, emerging technology, and innovation-driven industries.
PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics
Dallas, TX, March 11, 2026 (GLOBE NEWSWIRE) -- PatentVest announced the completion of a strategic intellectual property engagement with Porosome Therapeutics, Inc., a biotechnology company developing a first-in-class therapeutic platform designed to restore cellular secretion mechanisms.
Insider Buying: MDB Capital (NASDAQ:MDBH) Insider Acquires $14,696.45 in Stock
MDB Capital Holdings, LLC (NASDAQ: MDBH - Get Free Report) insider Christopher Marlett acquired 4,387 shares of the company's stock in a transaction that occurred on Wednesday, December 31st. The stock was acquired at an average price of $3.35 per share, with a total value of $14,696.45. Following the acquisition, the insider owned 166,720 shares in
Insider Buying: MDB Capital (NASDAQ:MDBH) Insider Acquires $13,992.00 in Stock
MDB Capital Holdings, LLC (NASDAQ: MDBH - Get Free Report) insider Christopher Marlett purchased 4,400 shares of MDB Capital stock in a transaction that occurred on Tuesday, December 30th. The shares were bought at an average price of $3.18 per share, with a total value of $13,992.00. Following the transaction, the insider owned 162,333 shares of
MDB Capital Holdings, LLC (MDBH) Q3 2025 Earnings Call Transcript
MDB Capital Holdings, LLC ( MDBH ) Q3 2025 Earnings Call November 20, 2025 4:30 PM EST Company Participants Tony Dammicci Christopher Marlett - Co-Founder, CEO & Chairman George Brandon - President, Head of Community Development & Director Presentation Tony Dammicci Welcome everyone to the MDB Capital Holdings' Third Quarter 2025 Update Conference Call. Thanks so much for joining us today.
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $133B Cardiac Diagnostics Market
Designed for investors, board members, and CEOs, the latest PatentVest Pulse report offers a strategic view of who's leading and why in the rapidly evolving cardiac diagnostics market Designed for investors, board members, and CEOs, the latest PatentVest Pulse report offers a strategic view of who's leading and why in the rapidly evolving cardiac diagnostics market
LD Micro Celebrates the 2,000th Company: MDB Capital Holdings (MDBH)
Santa Monica, California and Addison, Texas--(Newsfile Corp. - October 6, 2025) - LD Micro, a premier resource for microcap investors and a wholly owned subsidiary of Freedom US Markets, and MDB Capital Holdings, LLC (NASDAQ: MDBH) ("MDB"), a public venture platform focused on launching category-leading "Big Idea" companies, today announced an important milestone nearly two decades in the making. MDB has become LD Micro's 2,000th presenting company, marking a new chapter for a platform established in March 2006 by two visionaries seeking a better way to analyze the next generation of breakthrough companies.
PatentVest Welcomes Dr. Sarah Cork as Senior Patent Attorney, Expanding Life Sciences IP Leadership
Sarah Cork Ph.D. - Patent Attorney Dallas, TX, Sept.
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $188B Surgical Robotics Market
Designed for investors, board members, and CEOs, the latest PatentVest Pulse reveals who's actually leading and why in one of the most underpenetrated markets in medtech Designed for investors, board members, and CEOs, the latest PatentVest Pulse reveals who's actually leading and why in one of the most underpenetrated markets in medtech
New PatentVest Pulse Report Reveals IP Gaps in Billion-Dollar Humanoid Robotics Startups
Despite rising valuations, most humanoid robotics startups remain underprotected—leaving long-term value at risk Despite rising valuations, most humanoid robotics startups remain underprotected—leaving long-term value at risk
MDB Capital Holdings, LLC (MDBH) Q4 2024 Earnings Call Transcript
MDB Capital Holdings, LLC (NASDAQ:MDBH ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants Kevin Cotter – Managing Director-Investment Banking Chris Marlett – Chief Executive Officer and Co-Founder Jeremy James – Chief Financial Officer Gary Schuman – Broker Dealer Chief Financial Officer and Head-Compliance Conference Call Participants Kevin Cotter [Call Starts Abruptly] will follow the formal presentation. If you have questions during the presentation, you can type them into the chat to be answered during the question-and-answer period.